Build Your Own Case Study | Redefining MASLD/MASH Care: Personalized Strategies for Assessment, Diagnosis and Management

Health Care Providers (HCPs) in the endocrinology specialty setting are challenged to be knowledgeable of the pathophysiology of MASLD (metabolic dysfunction-associated steatotic liver disease) and MASH (metabolic dysfunction-associated steatohepatitis) and its associated risk factors, as well as feel confident around how and when to order noninvasive diagnostic tests to prevent the emergence of more severe complications and stay on top of current guidelines and emerging treatment options.

Explore this interactive learning format, Build Your Own Case Study (BYOCS), titled Redefining MASLD/MASH Care: Personalized Strategies for Assessment, Diagnosis and Management.

This collaborative effort, in conjunction with Global Liver Institute, provides expert guidance and clinical best practices for identifying comorbidities and risk factors for clinically significant fibrosis, understanding the role of non-invasive testing and risk stratification, and describing and evaluating current guidelines and emerging therapies for the management of MASLD/MASH.

By participating in this activity, you will gain valuable insights into effectively addressing MASLD/MASH for improved patient health.